These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2012068)

  • 1. Eosinophilia resulting from administration of recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in a patient with T-gamma lymphoproliferative disease.
    Gonzales-Chambers R; Rosenfeld C; Winkelstein A; Dameshek L
    Am J Hematol; 1991 Feb; 36(2):157-9. PubMed ID: 2012068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of T-gamma lymphoproliferative disease with human-recombinant granulocyte colony stimulating factor.
    Lang DF; Rosenfeld CS; Diamond HS; Shadduck RK; Zeigler ZR
    Am J Hematol; 1992 May; 40(1):66-8. PubMed ID: 1373559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
    Hovgaard DJ; Nissen NI
    J Clin Oncol; 1992 Mar; 10(3):390-7. PubMed ID: 1740678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia.
    Ganser A; Ottmann OG; Erdmann H; Schulz G; Hoelzer D
    Ann Intern Med; 1989 Dec; 111(11):887-92. PubMed ID: 2683920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy.
    Gerhartz HH; Stern AC; Wolf-Hornung B; Kazempour M; Schmetzer H; Gugerli U; Jones TC; Wilmanns W
    Leuk Res; 1993 Feb; 17(2):175-85. PubMed ID: 8429694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative disorder of granular lymphocytes associated with severe neutropenia. Response to granulocyte colony-stimulating factor.
    Cooper DL; Henderson-Bakas M; Berliner N
    Cancer; 1993 Sep; 72(5):1607-11. PubMed ID: 7688654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation.
    De Witte T; Gratwohl A; Van Der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
    Blood; 1992 Mar; 79(5):1359-65. PubMed ID: 1536959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma.
    Hamm J; Schiller JH; Cuffie C; Oken M; Fisher RI; Shepherd F; Kaiser G
    J Clin Oncol; 1994 Dec; 12(12):2667-76. PubMed ID: 7989942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.
    Kaku K; Takahashi M; Moriyama Y; Nakahata T; Masaoka T; Yoshida Y; Shibata A; Kaneko T; Miwa S
    Leuk Lymphoma; 1993 Oct; 11(3-4):229-38. PubMed ID: 8260897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous versus subcutaneous recombinant human granulocyte-macrophage colony-stimulating factor in patients with primary myelodysplasia.
    Rosenfeld CS; Sulecki M; Evans C; Shadduck RK
    Exp Hematol; 1991 May; 19(4):273-7. PubMed ID: 2055292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in children after intravenous and subcutaneous administration.
    Stute N; Furman WL; Schell M; Evans WE
    J Pharm Sci; 1995 Jul; 84(7):824-8. PubMed ID: 7562431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of low-dose recombinant human granulocyte-macrophage colony-stimulating factor in chronic neutropenia.
    Kaczmarski RS; Pozniak A; Lakhani A; Harvey E; Mufti GJ
    Br J Haematol; 1993 Jun; 84(2):338-40. PubMed ID: 8398839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
    Lieschke GJ; Maher D; Cebon J; O'Connor M; Green M; Sheridan W; Boyd A; Rallings M; Bonnem E; Metcalf D
    Ann Intern Med; 1989 Mar; 110(5):357-64. PubMed ID: 2644886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors.
    Nemunaitis J; Anasetti C; Storb R; Bianco JA; Buckner CD; Onetto N; Martin P; Sanders J; Sullivan K; Mori M
    Blood; 1992 May; 79(10):2572-7. PubMed ID: 1586709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
    Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
    J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human granulocyte-macrophage colony-stimulating factor in acquired or chemotherapy-induced neutropenia. An open clinical trial.
    Piguet D; Chapuis B
    Acta Oncol; 1994; 33(6):639-43. PubMed ID: 7946441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.